ALAViDA Webinar Hosted by The Leslie Group Addresses Common Myths and Current Challenges with Substance Use in the Post-COVID Workplace.
“The post-covid tsunami of mental health challenges is coming, and this webinar will provide employers with strategies to support their teams and mitigate future risks.”— Shawn Leslie
VANCOUVER, BC, CANADA, April 6, 2021 /EINPresswire.com/ — As businesses begin to prepare for a post-pandemic world, ALAViDA – Canada’s leading virtual provider of evidence-based substance use treatment – will present a webinar April 15th titled, “Common Myths and Current Challenges with Substance Use in the Post-COVID Workplace.” Hosted by The Leslie Group, Canada’s fastest-growing independent employee benefits consulting firm with clients located across the country, the webinar offers powerful insights and compelling reasons to rethink how employers can provide cost-effective, evidence-based substance use treatment as part of a workplace benefits program.
More people are drinking more often during COVID-19. In a world where only one in 10 seek treatment due to stigma, sufferers typically get help only when confronted with a crisis. The longer they wait, the worse the problem will get – for them – and their employer. Substance use costs Canadian companies some $15.7 billion each year, in absences, increased healthcare costs, disability claims, and lost productivity. Alcohol costs employers over six times more than all other substances combined, but early intervention is proven to be more successful than traditional approaches at reducing long-term health consequences associated with drinking issues. It is estimated that effective substance use treatment nets a 565 per cent return on investment.
To learn more visit www.lesliegroup.com
Access the ALAViDA TRAiL app.
ALAViDA, part of the LifeSpeak Inc. (TSX: LSPK) family of companies, is a leading virtual care provider focused on the science of substance use management. It offers a one-stop-shop approach for any level of substance use disorder – alcohol and drugs – mild, moderate and severe. ALAViDA connects patients with behavioural coaches, therapists and physicians who work as a team to deliver personalized care right to their smartphones. ALAViDA is an employee benefit with varying plans and personalized therapeutic programs, which has proven to minimize time out of the workplace. Traditional rehab often costs $30,000 or more a month. ALAViDA’s program is a mere fraction of that. More than 79 per cent of those signed on reported increased control and 86 per cent reduced substance use. To learn more visit ALAViDA.co For information on corporate programs or to establish a referral relationship contact [email protected]
Visit us on social media: